Australia Competition Commission Lays Out Claims Against Pfizer
This article was originally published in PharmAsia News
Executive Summary
Australia's Competition and Consumer Commission has filed federal court papers alleging Pfizer maintained a $35 million account to get pharmacists to sell its own generic of Lipitor (atorvastatin) cholesterol drug.